Skip to main content
Erschienen in: AIDS and Behavior 6/2012

01.08.2012 | Original Paper

Using Conjoint Analysis to Measure the Acceptability of Rectal Microbicides Among Men Who Have Sex with Men in Four South American Cities

verfasst von: Janni J. Kinsler, William E. Cunningham, César R. Nureña, Carsten Nadjat-Haiem, Beatriz Grinsztejn, Martin Casapia, Orlando Montoya-Herrera, Jorge Sánchez, Jerome T. Galea

Erschienen in: AIDS and Behavior | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Conjoint Analysis (CJA), a statistical market-based technique that assesses the value consumers place on product characteristics, may be used to predict acceptability of hypothetical products. Rectal Microbicides (RM)—substances that would prevent HIV infection during receptive anal intercourse—will require acceptability data from potential users in multiple settings to inform the development process by providing valuable information on desirable product characteristics and issues surrounding potential barriers to product use. This study applied CJA to explore the acceptability of eight different hypothetical RM among 128 MSM in Lima and Iquitos, Peru; Guayaquil, Ecuador; and Rio de Janeiro, Brazil. Overall RM acceptability was highest in Guayaquil and lowest in Rio. Product effectiveness had the greatest impact on acceptability in all four cities, but the impact of other product characteristics varied by city. This study demonstrates that MSM from the same region but from different cities place different values on RM characteristics that could impact uptake of an actual RM. Understanding specific consumer preferences is crucial during RM product development, clinical trials and eventual product dissemination.
Literatur
1.
Zurück zum Zitat Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.PubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.PubMedCrossRef
2.
Zurück zum Zitat Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCrossRef Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.PubMedCrossRef
5.
Zurück zum Zitat Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, ‘Praneem polyherbal tablet’, in Pune, India. Trans R Soc Trop Med Hyg. 2010;104(6):412–5.PubMedCrossRef Joglekar NS, Joshi SN, Deshpande SS, Parkhe AN, Katti UR, Mehendale SM. Acceptability and adherence: findings from a Phase II study of a candidate vaginal microbicide, ‘Praneem polyherbal tablet’, in Pune, India. Trans R Soc Trop Med Hyg. 2010;104(6):412–5.PubMedCrossRef
6.
Zurück zum Zitat McGowan I. Rectal microbicides: can we make them and will people use them? AIDS Behav. 2011;15(Suppl 1):S66–71.PubMedCrossRef McGowan I. Rectal microbicides: can we make them and will people use them? AIDS Behav. 2011;15(Suppl 1):S66–71.PubMedCrossRef
7.
Zurück zum Zitat International Rectal Microbicides Advocates (IRMA). From promise to product: advancing rectal microbicide research and advocacy, Chicago; 2010. International Rectal Microbicides Advocates (IRMA). From promise to product: advancing rectal microbicide research and advocacy, Chicago; 2010.
8.
Zurück zum Zitat Carballo-Diéguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.PubMedCrossRef Carballo-Diéguez A, Dolezal C, Bauermeister JA, O’Brien W, Ventuneac A, Mayer K. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. Sex Transm Infect. 2008;84(6):483–7.PubMedCrossRef
9.
Zurück zum Zitat Carballo-Diéguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008;12(6):860–6.PubMedCrossRef Carballo-Diéguez A, Bauermeister JA, Ventuneac A, Dolezal C, Balan I, Remien RH. The use of rectal douches among HIV-uninfected and infected men who have unprotected receptive anal intercourse: implications for rectal microbicides. AIDS Behav. 2008;12(6):860–6.PubMedCrossRef
10.
Zurück zum Zitat Carballo-Diéguez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K. Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men. Sex Transm Dis. 2009;37(4):228–9. Carballo-Diéguez A, Bauermeister J, Ventuneac A, Dolezal C, Mayer K. Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men. Sex Transm Dis. 2009;37(4):228–9.
11.
Zurück zum Zitat Carroll J, Green P. Psychometric methods in marketing research: part I, conjoint analysis. J Mark Res. 1995;XXXII:385–9.CrossRef Carroll J, Green P. Psychometric methods in marketing research: part I, conjoint analysis. J Mark Res. 1995;XXXII:385–9.CrossRef
12.
Zurück zum Zitat Green P, Rao V. Conjoint measurement for quantifying judgmental data. J Mark Res. 1971;8(3):355–63.CrossRef Green P, Rao V. Conjoint measurement for quantifying judgmental data. J Mark Res. 1971;8(3):355–63.CrossRef
13.
Zurück zum Zitat Green P, Srinivasan V. Conjoint analysis in marketing research: new developments and directions. J Mark Res. 1990;54:3–19. Green P, Srinivasan V. Conjoint analysis in marketing research: new developments and directions. J Mark Res. 1990;54:3–19.
14.
Zurück zum Zitat Marshall P, Bradlow E. A unified approach to conjoint analysis models. J Am Stat Assoc. 2002;97(459):674–82.CrossRef Marshall P, Bradlow E. A unified approach to conjoint analysis models. J Am Stat Assoc. 2002;97(459):674–82.CrossRef
15.
Zurück zum Zitat Beusterien KM, Dziekan K, Flood E, Harding G, Jordan JC. Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment. Value Health. 2005;8(4):453–61.PubMedCrossRef Beusterien KM, Dziekan K, Flood E, Harding G, Jordan JC. Understanding patient preferences for HIV medications using adaptive conjoint analysis: feasibility assessment. Value Health. 2005;8(4):453–61.PubMedCrossRef
16.
Zurück zum Zitat Akkazieva B, Gulacsi L, Brandtmuller A, Pentek M, Bridges JF. Patients’ preferences for healthcare system reforms in Hungary: a conjoint analysis. Appl Health Econ Health Policy. 2006;5(3):189–98.PubMedCrossRef Akkazieva B, Gulacsi L, Brandtmuller A, Pentek M, Bridges JF. Patients’ preferences for healthcare system reforms in Hungary: a conjoint analysis. Appl Health Econ Health Policy. 2006;5(3):189–98.PubMedCrossRef
17.
Zurück zum Zitat Aristides M, Chen J, Schulz M, Williamson E, Clarke S, Grant K. Conjoint analysis of a new chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced colorectal cancer. Pharmacoeconomics. 2002;20(11):775–84.PubMedCrossRef Aristides M, Chen J, Schulz M, Williamson E, Clarke S, Grant K. Conjoint analysis of a new chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced colorectal cancer. Pharmacoeconomics. 2002;20(11):775–84.PubMedCrossRef
18.
Zurück zum Zitat Bhargava JS, Bhan-Bhargava A, Foss AJ, King AJ. Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis. Br J Ophthalmol. 2008;92(12):1601–5.PubMedCrossRef Bhargava JS, Bhan-Bhargava A, Foss AJ, King AJ. Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis. Br J Ophthalmol. 2008;92(12):1601–5.PubMedCrossRef
19.
Zurück zum Zitat Bishai D, Brice R, Girod I, Saleh A, Ehreth J. Conjoint analysis of French and German parents’ willingness to pay for meningococcal vaccine. Pharmacoeconomics. 2007;25(2):143–54.PubMedCrossRef Bishai D, Brice R, Girod I, Saleh A, Ehreth J. Conjoint analysis of French and German parents’ willingness to pay for meningococcal vaccine. Pharmacoeconomics. 2007;25(2):143–54.PubMedCrossRef
20.
Zurück zum Zitat Bishop AJ, Marteau TM, Armstrong D, et al. Women and health care professionals’ preferences for Down’s syndrome screening tests: a conjoint analysis study. BJOG. 2004;111(8):775–9.PubMedCrossRef Bishop AJ, Marteau TM, Armstrong D, et al. Women and health care professionals’ preferences for Down’s syndrome screening tests: a conjoint analysis study. BJOG. 2004;111(8):775–9.PubMedCrossRef
21.
Zurück zum Zitat Costa ML, de Cassia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol. 2006;13(6):843–50.PubMedCrossRef Costa ML, de Cassia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol. 2006;13(6):843–50.PubMedCrossRef
22.
Zurück zum Zitat Cunningham CE, Deal K, Rimas H, Chen Y, Buchanan DH, Sdao-Jarvie K. Providing information to parents of children with mental health problems: a discrete choice conjoint analysis of professional preferences. J Abnorm Child Psychol. 2009;37(8):1089–102.PubMedCrossRef Cunningham CE, Deal K, Rimas H, Chen Y, Buchanan DH, Sdao-Jarvie K. Providing information to parents of children with mental health problems: a discrete choice conjoint analysis of professional preferences. J Abnorm Child Psychol. 2009;37(8):1089–102.PubMedCrossRef
23.
Zurück zum Zitat Fisher K, Orkin F, Frazer C. Utilizing conjoint analysis to explicate health care decision making by emergency department nurses: a feasibility study. Appl Nurs Res. 2010;23(1):30–5.PubMedCrossRef Fisher K, Orkin F, Frazer C. Utilizing conjoint analysis to explicate health care decision making by emergency department nurses: a feasibility study. Appl Nurs Res. 2010;23(1):30–5.PubMedCrossRef
24.
Zurück zum Zitat Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–3.PubMedCrossRef Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ. 2000;320(7248):1530–3.PubMedCrossRef
25.
Zurück zum Zitat Lancsar EJ, Hall JP, King M, et al. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology. 2007;12(1):127–36.PubMedCrossRef Lancsar EJ, Hall JP, King M, et al. Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology. 2007;12(1):127–36.PubMedCrossRef
26.
Zurück zum Zitat Stone VE, Jordan J, Tolson J, Miller R, Pilon T. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr. 2004;36(3):808–16.PubMedCrossRef Stone VE, Jordan J, Tolson J, Miller R, Pilon T. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr. 2004;36(3):808–16.PubMedCrossRef
27.
Zurück zum Zitat Newman PA, Duan N, Lee SJ, et al. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine. 2006;24(12):2094–101.PubMedCrossRef Newman PA, Duan N, Lee SJ, et al. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics. Vaccine. 2006;24(12):2094–101.PubMedCrossRef
28.
Zurück zum Zitat Galea J, Kinsler J, Salazar X, et al. Acceptability of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy: barriers and facilitators to PrEP uptake among at-risk Peruvian populations. Int J STD AIDS. 2010;22:256–62.CrossRef Galea J, Kinsler J, Salazar X, et al. Acceptability of pre-exposure prophylaxis (PrEP) as an HIV prevention strategy: barriers and facilitators to PrEP uptake among at-risk Peruvian populations. Int J STD AIDS. 2010;22:256–62.CrossRef
29.
Zurück zum Zitat Lancsar E, Savage E. Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory. Health Econ. 2004;13(9):901–7.PubMedCrossRef Lancsar E, Savage E. Deriving welfare measures from discrete choice experiments: inconsistency between current methods and random utility and welfare theory. Health Econ. 2004;13(9):901–7.PubMedCrossRef
30.
Zurück zum Zitat Hunink M, Glasziou P, Siegel J, et al. Decision making in health and medicine: integrating evidence and values. Cambridge: Cambridge University Press; 2001. Hunink M, Glasziou P, Siegel J, et al. Decision making in health and medicine: integrating evidence and values. Cambridge: Cambridge University Press; 2001.
31.
Zurück zum Zitat UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS. Accessed 10 April 2011. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS. Accessed 10 April 2011.
32.
Zurück zum Zitat Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med. 2007;4(12):e339.PubMedCrossRef Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med. 2007;4(12):e339.PubMedCrossRef
33.
Zurück zum Zitat Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–53.PubMedCrossRef Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–53.PubMedCrossRef
34.
Zurück zum Zitat Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–11.PubMedCrossRef Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–11.PubMedCrossRef
35.
Zurück zum Zitat Foss A, Johnson H, Prudden H, et al. Modelling the potential impact on HIV transmission of a rectal microbicide used by men who have sex with men and the effects of condom substitution. Microbicides. Pittsburgh, 2010 [abstract WEPE0340]. Foss A, Johnson H, Prudden H, et al. Modelling the potential impact on HIV transmission of a rectal microbicide used by men who have sex with men and the effects of condom substitution. Microbicides. Pittsburgh, 2010 [abstract WEPE0340].
37.
Zurück zum Zitat Holmes WR, Maher L, Rosenthal SL. Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health. 2008;5(3):273–8.PubMedCrossRef Holmes WR, Maher L, Rosenthal SL. Attitudes of men in an Australian male tolerance study towards microbicide use. Sex Health. 2008;5(3):273–8.PubMedCrossRef
38.
Zurück zum Zitat Orme B. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010. Orme B. Getting started with conjoint analysis: strategies for product design and pricing research. 2nd ed. Madison: Research Publishers LLC; 2010.
39.
Zurück zum Zitat Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.PubMedCrossRef Carballo-Diéguez A, Exner T, Dolezal C, Pickard R, Lin P, Mayer KH. Rectal microbicide acceptability: results of a volume escalation trial. Sex Transm Dis. 2007;34(4):224–9.PubMedCrossRef
40.
Zurück zum Zitat Pickett J, LeBlanc MA, Gorbach P, Murphy R, Javanbakht M. International lubricant use behaviors for anal intercourse. XVII international AIDS conference. Mexico City, 2008. [abstract WEPE0275]. Pickett J, LeBlanc MA, Gorbach P, Murphy R, Javanbakht M. International lubricant use behaviors for anal intercourse. XVII international AIDS conference. Mexico City, 2008. [abstract WEPE0275].
41.
Zurück zum Zitat Anton P, Saunders T, Adler A, et al. A phase 1 safety and acceptability study of the UC-781 microbicide gel applied rectally in HIV seronegative adults: an interim safety report at 50% completion. Microbicides. New Delhi, 2008. [abstract BO5-290]. Anton P, Saunders T, Adler A, et al. A phase 1 safety and acceptability study of the UC-781 microbicide gel applied rectally in HIV seronegative adults: an interim safety report at 50% completion. Microbicides. New Delhi, 2008. [abstract BO5-290].
42.
Zurück zum Zitat Kinsler JJ, Galea JT, Peinado J, Segura P, Montano SM, Sánchez J. Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: implications for rectal microbicides as an HIV prevention strategy. Int J STD AIDS. 2010;21(8):567–72.PubMedCrossRef Kinsler JJ, Galea JT, Peinado J, Segura P, Montano SM, Sánchez J. Lubricant use among men who have sex with men reporting receptive anal intercourse in Peru: implications for rectal microbicides as an HIV prevention strategy. Int J STD AIDS. 2010;21(8):567–72.PubMedCrossRef
43.
Zurück zum Zitat Anton P, Cranston R, Carballo-Diéguez A, et al. RMP-02/MTN-006: a phase 1 placebo-controlled trial of rectally applied 1% vaginal TFV gel with comparison to oral TDF. The 18th conference on retroviruses and opportunistic infections, Boston, USA; 2011. Anton P, Cranston R, Carballo-Diéguez A, et al. RMP-02/MTN-006: a phase 1 placebo-controlled trial of rectally applied 1% vaginal TFV gel with comparison to oral TDF. The 18th conference on retroviruses and opportunistic infections, Boston, USA; 2011.
44.
Zurück zum Zitat Galea J, Kinsler J, Segura P, Peinado J, Sánchez J. The use of rectal douches among peruvian MSM: implications for rectal microbicides. Microbicides, Pittsburgh, 2010. [abstract 162]. Galea J, Kinsler J, Segura P, Peinado J, Sánchez J. The use of rectal douches among peruvian MSM: implications for rectal microbicides. Microbicides, Pittsburgh, 2010. [abstract 162].
45.
Zurück zum Zitat Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol Med. 2010;17(1):99–111.PubMedCrossRef Saethre EJ, Stadler J. Gelling medical knowledge: innovative pharmaceuticals, experience, and perceptions of efficacy. Anthropol Med. 2010;17(1):99–111.PubMedCrossRef
46.
Zurück zum Zitat Vail JG, Cohen JA, Kelly KL. Improving topical microbicide applicators for use in resource-poor settings. Am J Public Health. 2004;94(7):1089–92.PubMedCrossRef Vail JG, Cohen JA, Kelly KL. Improving topical microbicide applicators for use in resource-poor settings. Am J Public Health. 2004;94(7):1089–92.PubMedCrossRef
47.
Zurück zum Zitat Cohen JA, Steele MS, Urena FI, Beksinska ME. Microbicide applicators: understanding design preferences among women in the dominican republic and South Africa. Sex Transm Dis. 2007;34(1):15–9.PubMedCrossRef Cohen JA, Steele MS, Urena FI, Beksinska ME. Microbicide applicators: understanding design preferences among women in the dominican republic and South Africa. Sex Transm Dis. 2007;34(1):15–9.PubMedCrossRef
48.
Zurück zum Zitat Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ. 2006;332(7541):605–7.PubMedCrossRef Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ. 2006;332(7541):605–7.PubMedCrossRef
49.
Zurück zum Zitat Pinkerton SD. Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal. 2001;21(4):727–36.PubMedCrossRef Pinkerton SD. Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations. Risk Anal. 2001;21(4):727–36.PubMedCrossRef
50.
Zurück zum Zitat Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr. 2004;37(3):1393–403.PubMedCrossRef Newman PA, Duan N, Rudy ET, Roberts KJ, Swendeman D. Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV. J Acquir Immune Defic Syndr. 2004;37(3):1393–403.PubMedCrossRef
Metadaten
Titel
Using Conjoint Analysis to Measure the Acceptability of Rectal Microbicides Among Men Who Have Sex with Men in Four South American Cities
verfasst von
Janni J. Kinsler
William E. Cunningham
César R. Nureña
Carsten Nadjat-Haiem
Beatriz Grinsztejn
Martin Casapia
Orlando Montoya-Herrera
Jorge Sánchez
Jerome T. Galea
Publikationsdatum
01.08.2012
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 6/2012
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-011-0045-5

Weitere Artikel der Ausgabe 6/2012

AIDS and Behavior 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.